Pfizer's 7% Dividend: Income Gem or Value Trap?

Pfizer (NYSE: PFE) is attracting dividend investors with a current yield of 7% amidst a 31% decline in share value over the past five years. While this payout may seem appealing compared to bond yields of 4% to 5%, investors should consider whether it represents a value trap rather than a genuine income opportunity.

Want More Context? 🔎